Ndu Adora 4
4 · ACADIA PHARMACEUTICALS INC · Filed Oct 15, 2024
Insider Transaction Report
Form 4
Ndu Adora
Director
Transactions
- Exercise/Conversion
Common Stock
2024-10-12+4,381→ 15,414 total - Exercise/Conversion
Restricted Stock Units
2024-10-12−4,381→ 0 total→ Common Stock (4,381 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.
- [F2]The restricted stock units vested in two equal annual installments on each of October 12, 2023 and October 12, 2024.